This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Virginia Commonwealth University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Daniel Kwame Afosah
Introduction
Daniel Kwame Afosah is a notable inventor based in Richmond, VA. He has made significant strides in the field of cancer research through his innovative work on anti-cancer agents. His contributions are particularly focused on the development of lipidic analogs that target cancer stem cells.
Latest Patents
Daniel Kwame Afosah holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These agents display promising in vivo anti-cancer activity by selectively inhibiting cancer stem cells while sparing adult or hematopoietic stem cells. The compounds demonstrate high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. He has 1 patent to his name.
Career Highlights
Afosah is affiliated with Virginia Commonwealth University, where he continues to advance his research in cancer therapeutics. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Umesh R Desai and Balaji Nagarajan, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Daniel Kwame Afosah's innovative work in developing anti-cancer agents highlights his dedication to improving cancer treatment. His research has the potential to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile